392 related articles for article (PubMed ID: 18088505)
1. Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.
Ahmed S; Vo NT; Thalhammer T; Thalhammer F; Gattringer KB; Jäger W
J Pharm Pharmacol; 2008 Jan; 60(1):55-62. PubMed ID: 18088505
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and disposition of resveratrol in the isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides.
Maier-Salamon A; Hagenauer B; Reznicek G; Szekeres T; Thalhammer T; Jäger W
J Pharm Sci; 2008 Apr; 97(4):1615-28. PubMed ID: 17724663
[TBL] [Abstract][Full Text] [Related]
3. Biliary excretion of flavopiridol and its glucuronides in the isolated perfused rat liver: role of multidrug resistance protein 2 (Mrp2).
Jäger W; Gehring E; Hagenauer B; Aust S; Senderowicz A; Thalhammer T
Life Sci; 2003 Oct; 73(22):2841-54. PubMed ID: 14511769
[TBL] [Abstract][Full Text] [Related]
4. Hepatic metabolism and biliary excretion of valerenic acid in isolated perfused rat livers: role of Mrp2 (Abcc2).
Maier-Salamon A; Trauner G; Hiltscher R; Reznicek G; Kopp B; Thalhammer T; Jäger W
J Pharm Sci; 2009 Oct; 98(10):3839-49. PubMed ID: 19156843
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of UCN-01 in isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides.
Hagenauer B; Maier-Salamon A; Thalhammer T; Zöllner P; Senderowicz A; Jäger W
Oncol Rep; 2004 May; 11(5):1069-75. PubMed ID: 15069549
[TBL] [Abstract][Full Text] [Related]
6. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats.
Xiong H; Turner KC; Ward ES; Jansen PL; Brouwer KL
J Pharmacol Exp Ther; 2000 Nov; 295(2):512-8. PubMed ID: 11046083
[TBL] [Abstract][Full Text] [Related]
7. Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2).
Miranda SR; Lee JK; Brouwer KL; Wen Z; Smith PC; Hawke RL
Drug Metab Dispos; 2008 Nov; 36(11):2219-26. PubMed ID: 18687803
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance-associated protein 2 is primarily responsible for the biliary excretion of fexofenadine in mice.
Tian X; Zamek-Gliszczynski MJ; Li J; Bridges AS; Nezasa K; Patel NJ; Raub TJ; Brouwer KL
Drug Metab Dispos; 2008 Jan; 36(1):61-4. PubMed ID: 17913796
[TBL] [Abstract][Full Text] [Related]
9. Multiple mechanisms are involved in the biliary excretion of acetaminophen sulfate in the rat: role of Mrp2 and Bcrp1.
Zamek-Gliszczynski MJ; Hoffmaster KA; Tian X; Zhao R; Polli JW; Humphreys JE; Webster LO; Bridges AS; Kalvass JC; Brouwer KL
Drug Metab Dispos; 2005 Aug; 33(8):1158-65. PubMed ID: 15860656
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment.
Xiong H; Suzuki H; Sugiyama Y; Meier PJ; Pollack GM; Brouwer KL
Drug Metab Dispos; 2002 Sep; 30(9):962-9. PubMed ID: 12167560
[TBL] [Abstract][Full Text] [Related]
11. Role of Mrp2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: effect of cyclosporine.
Westley IS; Brogan LR; Morris RG; Evans AM; Sallustio BC
Drug Metab Dispos; 2006 Feb; 34(2):261-6. PubMed ID: 16272406
[TBL] [Abstract][Full Text] [Related]
12. 4-Hydroxyacetophenone-induced choleresis in rats is mediated by the Mrp2-dependent biliary secretion of its glucuronide conjugate.
Mahagita C; Tanphichai K; Suksamrarn A; Ballatori N; Piyachaturawat P
Pharm Res; 2006 Nov; 23(11):2603-10. PubMed ID: 17009103
[TBL] [Abstract][Full Text] [Related]
13. Decreased hepatic breast cancer resistance protein expression and function in multidrug resistance-associated protein 2-deficient (TR⁻) rats.
Yue W; Lee JK; Abe K; Sugiyama Y; Brouwer KL
Drug Metab Dispos; 2011 Mar; 39(3):441-7. PubMed ID: 21106720
[TBL] [Abstract][Full Text] [Related]
14. Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat.
Zamek-Gliszczynski MJ; Hoffmaster KA; Humphreys JE; Tian X; Nezasa K; Brouwer KL
J Pharmacol Exp Ther; 2006 Oct; 319(1):459-67. PubMed ID: 16857726
[TBL] [Abstract][Full Text] [Related]
15. Phenobarbital alters hepatic Mrp2 function by direct and indirect interactions.
Patel NJ; Zamek-Gliszczynski MJ; Zhang P; Han YH; Jansen PL; Meier PJ; Stieger B; Brouwer KL
Mol Pharmacol; 2003 Jul; 64(1):154-9. PubMed ID: 12815171
[TBL] [Abstract][Full Text] [Related]
16. Abolition of valproate-derived choleresis in the Mrp2 transporter-deficient rat.
Wright AW; Dickinson RG
J Pharmacol Exp Ther; 2004 Aug; 310(2):584-8. PubMed ID: 15075379
[TBL] [Abstract][Full Text] [Related]
17. Hepatobiliary disposition of thyroid hormone in Mrp2-deficient TR- rats: reduced biliary excretion of thyroxine glucuronide does not prevent xenobiotic-induced hypothyroidism.
Lecureux L; Dieter MZ; Nelson DM; Watson L; Wong H; Gemzik B; Klaassen CD; Lehman-McKeeman LD
Toxicol Sci; 2009 Apr; 108(2):482-91. PubMed ID: 19211616
[TBL] [Abstract][Full Text] [Related]
18. The important role of Bcrp (Abcg2) in the biliary excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in mice.
Zamek-Gliszczynski MJ; Nezasa K; Tian X; Kalvass JC; Patel NJ; Raub TJ; Brouwer KL
Mol Pharmacol; 2006 Dec; 70(6):2127-33. PubMed ID: 16959944
[TBL] [Abstract][Full Text] [Related]
19. Interplay of phase II enzymes and transporters in futile cycling: influence of multidrug resistance-associated protein 2-mediated excretion of estradiol 17beta-D-glucuronide and its 3-sulfate metabolite on net sulfation in perfused TR(-) and Wistar rat liver preparations.
Sun H; Zeng YY; Pang KS
Drug Metab Dispos; 2010 May; 38(5):769-80. PubMed ID: 20124397
[TBL] [Abstract][Full Text] [Related]
20. Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systems.
Hoffmaster KA; Zamek-Gliszczynski MJ; Pollack GM; Brouwer KL
J Pharmacol Exp Ther; 2004 Dec; 311(3):1203-10. PubMed ID: 15302892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
